Millennium Pharmaceuticals, Inc. (MLNM)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
3044	135	0	MLNM

Emcee: icanpickem	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1019	good start to a rebound- 75% of daily volume already in first 35 minutes. But p	Taut Knot	-	6/5/2002
1018	FDA Grants Millennium's MLN341 and MLN518 Fast Track Status PR Newswire - Ju	manny t	-	6/5/2002
1017	08:48 ET Millennium Pharm granted fast track for cancer drugs (MLNM) 12.98: FDA	Exacctnt	-	6/5/2002
1016	The stock has been down something like 10 of the last 12 trading days. Also, vol	Elmer	-	6/5/2002
1015	<<Buying CORR was a stupid move that wasted plenty of shareholder value. N	Miljenko Zuanic	-	6/4/2002
1014	How about the $650M in debt they have to pay off in a year? Are they going to k	Londo	-	6/4/2002
1013	Absent Integrilin having safety problems, MLN341 failing in trials and nuclear w	Elmer	-	6/4/2002
1012	MLNM gets huge plug, 14:33 ET MLNM Millennium Pharm: positive comments by Robbi	manny t	-	6/4/2002
1011	From the co's web site: <i>Millennium has ten product candidates from	tom pope	-	6/4/2002
1010	<< and expects to bring 1-2 products to mkt per year >> Is this rea	David Howe	-	6/4/2002
1009	Just bought my first shares today and hope to learn from those that have followe	David Howe	-	6/4/2002
1008	<the market is very inefficient and swings in a manic-depressive cycle> Mu	Elmer	-	6/4/2002
1007	jmho, those who think the market is the best arbiter of price are wrong. otherwi	bob zagorin	-	6/4/2002
1006	<good thing they didn't announce they were on track with consensus> Am	Elmer	-	6/4/2002
1005	good thing they didn't announce they were on track with consensus, the stock	tom pope	-	6/4/2002
1004	Book value per share is about $11. With today's decline, even Graham and Dod	Elmer	-	6/4/2002
1003	If peak rate is at 2X today (are you talking about grow rate acceleration or pea	Miljenko Zuanic	-	6/4/2002
1002	wilder, another important aspect to consider is ave's(mlnm's partner) d	software salesperson	-	6/4/2002
1001	sold, I think with an immaterial deferred earn-out, but my memory is weak on tha	keokalani'nui	-	6/4/2002
1000	I think peak will be twice existing run rate.	keokalani'nui	-	6/4/2002
999	<<Integrilin $176m annual RR x 13 = 2.2b>> 50% owned by SGP, so div	rkrw	-	6/3/2002
998	Do they still get Campath royalties or did they sell that? It's cheapo!	Elmer	-	6/3/2002
997	MLNM: $13.60 = $3.6b MC Integrilin $176m annual RR x 13 = 2.2b Cash - debt =	keokalani'nui	-	6/3/2002
996	Agencourt Bioscience Provides Genomic Services to Leading Biopharmaceutical Comp	bob zagorin	-	6/3/2002
995	ASCO update from Bull Market bio MILLENNIUM PHARMACEUTICALS (MLNM, $16, down 3%	bob zagorin	-	5/31/2002

Go to reply# or date (mm/dd/yy):